| Literature DB >> 2127424 |
D D Von Hoff1, T R Fleming, J S Macdonald, P J Goodman, J Van Damme, T D Brown, T O'Rourke, L G Feun, M D Keppen.
Abstract
Thirty evaluable patients with advanced carcinoma of the pancreas received treatment with either daily x 5 bolus or continuous infusion x 5 days recombinant gamma-interferon. No responses were noted. Major toxicities included fever, hypotension, and flu-like symptoms. gamma-Interferon does not appear to be an active single agent for patients with advanced pancreatic cancer.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2127424
Source DB: PubMed Journal: J Biol Response Mod ISSN： 0732-6580